Assessment of DHA on Reducing Early Preterm Birth
common.study.values.description
“Assessment of DHA On Reducing Early Preterm Birth”
The purpose of this study is to determine if giving a larger amount of DHA than currently included in some prenatal supplements can reduce early preterm birth (birth before 34 weeks of pregnancy).
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Docosahexaenoic acid - 800mg/day
All participants will take 1000 mg/DHA per day (1 capsule will be labeled with 200 mg; 2 capsules will be masked with 400 mg each)
Drug - Docosahexaenoic acid - 200mg/day
The control group will receive 1-capsule containing 200 mg DHA/d.
Placebo
Participants will receive 2 capsules (masked) containing half soybean oil and half corn oil equaling 800 mg.The soybean and corn oil combination does not contain DHA.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Assessment of DHA On Reducing Early Preterm Birth (ADORE Trial)
common.study.values.clinical-trial-id
NCT02626299
participant.views.study.view.id
mepBmb
